Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 3.83 billion. The enterprise value is 3.67 billion.

Market Cap	3.83B
Enterprise Value	3.67B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Medistim ASA has 18.25 million shares outstanding.

Current Share Class	18.25M
Shares Outstanding	18.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.83%
Owned by Institutions (%)	95.11%
Float	12.64M

Valuation Ratios

The trailing PE ratio is 31.19 and the forward PE ratio is 36.10.

PE Ratio	31.19
Forward PE	36.10
PS Ratio	6.35
PB Ratio	8.22
P/TBV Ratio	9.80
P/FCF Ratio	28.65
P/OCF Ratio	27.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.21, with an EV/FCF ratio of 27.48.

EV / Earnings	29.91
EV / Sales	6.08
EV / EBITDA	20.21
EV / EBIT	23.23
EV / FCF	27.48

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.

Current Ratio	3.91
Quick Ratio	2.52
Debt / Equity	0.06
Debt / EBITDA	0.14
Debt / FCF	0.20
Interest Coverage	194.08

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	17.26%
Return on Invested Capital (ROIC)	21.22%
Return on Capital Employed (ROCE)	31.82%
Revenue Per Employee	3.92M
Profits Per Employee	797,903
Employee Count	154
Asset Turnover	1.05
Inventory Turnover	0.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.89% in the last 52 weeks. The beta is 1.02, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	+19.89%
50-Day Moving Average	172.54
200-Day Moving Average	163.15
Relative Strength Index (RSI)	76.94
Average Volume (20 Days)	7,414

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 603.92 million and earned 122.88 million in profits.

Revenue	603.92M
Gross Profit	484.66M
Operating Income	158.18M
Pretax Income	160.29M
Net Income	122.88M
EBITDA	173.03M
EBIT	158.18M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 183.45 million in cash and 26.17 million in debt, giving a net cash position of 157.28 million or 8.62 per share.

Cash & Cash Equivalents	183.45M
Total Debt	26.17M
Net Cash	157.28M
Net Cash Per Share	8.62
Equity (Book Value)	466.42M
Book Value Per Share	n/a
Working Capital	350.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 139.81 million and capital expenditures -6.07 million, giving a free cash flow of 133.74 million.

Operating Cash Flow	139.81M
Capital Expenditures	-6.07M
Free Cash Flow	133.74M
FCF Per Share	7.33

Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.

Gross Margin	80.25%
Operating Margin	26.19%
Pretax Margin	26.54%
Profit Margin	20.35%
EBITDA Margin	28.65%
EBIT Margin	26.19%
FCF Margin	22.15%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 2.86%.

Dividend Per Share	6.00
Dividend Yield	2.86%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	n/a
Payout Ratio	67.07%
Buyback Yield	n/a
Shareholder Yield	2.86%
Earnings Yield	3.21%
FCF Yield	3.49%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a